Trifluoroacetic acid → HCID 19804288, compound
Reaction equation
Cl.C1(C(C2C=CC=CC=2)(C2C=CC=CC=2)[N:9]2[CH2:14][CH:13]([C:15]3[C:16]([O:20][CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][CH3:27])=[N:17][S:18][N:19]=3)[CH2:12][N:11]=[CH:10]2)C=CC=CC=1.[C:40]([OH:46])([C:42]([F:45])([F:44])[F:43])=[O:41]>>[F:43][C:42]([F:45])([F:44])[C:40]([OH:46])=[O:41].[CH2:21]([O:20][C:16]1[C:15]([CH:13]2[CH2:14][NH:9][CH:10]=[N:11][CH2:12]2)=[N:19][S:18][N:17]=1)[CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][CH3:27]Participants
3
Procedure
1-Triphenylmethyl-5(3(1-n-heptanoxy)-1,2,5-thiadiazol-4-yl)-1,4,5,6-tetrahydropyrimidine HCl (580 mg, 1 mmol) is dissolved in TFA (1 ml) and stirred overnight at room temperature. The TFA is evaporated and the resulting dark oil triturated with ether. After decanting the ether, the remaining solids are recrystallized from methanol/ether to give 344 mg (87%) white crystals identified by 300 MHz nmr, ms m/z=360.
Workup
- customThe TFA is evaporated
- customthe resulting dark oil triturated with ether
- customAfter decanting the ether
- customthe remaining solids are recrystallized from methanol/ether
Sources & evidence
- ORD record
- ord-ed2fedc0bd734d44b1d3eadb86c221aa
- Source dataset
- uspto-grants-1995_04
- Patent number
- US05403845
Reaction notes
Loading…